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Abstract:
White-rot fungi (WRF) mediated treatment can offer an environmentally friendly platform for the
removal of pharmaceuticals and personal care products (PPCPs) from wastewater. These PPCPs may
have adverse impacts on aquatic organisms and even human and thus their removal during wastewater
treatment is of significant interest to the water industry. Whole-cell WRF or their extracellular lignin
modifying enzymes (LMEs) have been reported to efficiently degrade PPCPs that are persistent to
conventional activated sludge process. WRF mediated treatment of PPCPs depends on a number of
factors including physicochemical properties of PPCPs (e.g., hydrophobicity and chemical structure) and
wastewater matrix (e.g., pH, temperature and dissolved constituents), type of WRF species and their
specific extracellular enzymes. This review critically analyzes the performance of whole-cell WRF and
their LMEs for the removal of PPCPs: particularly it offers insights into PPCP removal mechanisms (e.g.,
biosorption vs. biodegradation) and degradation pathways as well as the formation of intermediate
byproducts.
Keywords: White-rot fungi; lignin modifying enzymes (LMEs); Pharmaceuticals and personal care
products (PPCPs); Biodegradation; Redox-mediators; metabolites.
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1. Introduction
Trace organic contaminants (TrOCs) include diverse groups of chemicals such as pharmaceuticals and
personal care products (PPCPs), pesticides, surfactants and industrial chemicals. Due to their ineffective
removal by the conventional wastewater treatment processes, these TrOCs are commonly detected in the
aquatic environment including surface water and groundwater, and even seawater [1, 2, 3]. Most TrOCs
are biologically active even at trace concentrations (in the range of few ng/L) and can impose detrimental
impacts on aquatic environment as well as on human health [4, 5]. For example, PPCPs such as synthetic
hormones can induce endocrine disrupting effects in aquatic lives [6, 7]. Some of these TrOCs can also
accumulate in aquatic biota. Exposure to a non- lethal dose of antibiotics may result in the development of
antibiotic resistant genes in bacteria which is an emerging concern for human health according to the
World Health Organization [8, 9, 10, 11]. Biological treatment processes are environmentally friendly and
cost effective [12, 13, 14]. The conventional activated sludge and membrane bioreactor processes can
efficiently remove bulk organics, nutrients and pathogens. However, certain groups of PPCPs such as
significantly hydrophilic compounds and/or compounds with strong electron withdrawing functional
groups are poorly removed by the conventional biological treatment processes [2, 15, 16, 17]. Thus,
effective treatment processes to remove PPCPs from wastewater is urgently needed.
Extracellular enzymes of white-rot fungi (WRF) are characterized by their capacity to degrade the
complex structure of lignin, which also enables them to degrade a wide range of resistant pollutants
including

synthetic dyes, chlorophenols, polychlorinated biphenyls and polycyclic aromatic

hydrocarbons [18, 19, 20, 21, 22, 23]. WRF and their lignin modifying enzymes (LMEs) have been
investigated recently for the degradation of a broad spectrum of PPCPs [24, 25, 26, 27]. The potential of
WRF for the removal of PPCPs has been investigated mostly in batch mode. There are only a few studies
on continuous flow reactor configurations [24, 26, 28, 29, 30]. Despite a significant research effort,
efficient removal of PPCPs by WRF mediated treatment, their removal mechanisms and degradation
pathways remain largely to be elucidated. There have been a few excellent reviews on bioremediation of
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recalcitrant compounds by WRF and their LMEs [31, 32, 33, 34, 35]. However, aspects such as
comparative performance of different whole-cell WRF species, the impacts of different reactor
configurations as well as the performance under non-sterile environment deserve further attention.
Moreover, factors controlling the performance of the crude and/or purified LMEs for the degradation of
PPCPs, particularly the redox-mediator enhanced laccase systems remain largely unaddressed. This
critical review fills these gaps. Degradation mechanisms and pathways for the removal of PPCPs are also
critically discussed and the major metabolites or intermediate products following WRF treatment are
identified. In addition, the technological challenges associated with the continuous fungal bioreactors are
discussed and possible solutions are outlined. Directions for future research are also provided.

2. Enzymatic Systems of WRF
Several features of WRF make their application for PPCP removal attractive: (i) the non-specificity of
their enzyme systems, facilitating degradation of a broad spectrum of pollutants [36, 37]; (ii) the hyphal
growth, a defining property of filamentous fungi including WRF, enabling them to access pollutants by
colonizing fast; (iii) the secretion of extracellular enzymes enabling them to degrade pollutants with low
water solubility; and (iv) the ability of some WRF species to degrade pollutants in nutrient deficient
environment over a wide range of pH. Notable, however, is that resistant pollutant degradation by WRF is
a co-metabolic process, i.e., occurs in presence of an easily degradable substrate. Since, PPCP
degradation by WRF depends mainly on their enzyme systems, these are described in this section.
Three different types of extracellular LME, namely, lignin peroxidases (LiPs), laccase and manganesedependent peroxidases (MnPs), are secreted by WRF. The main difference between laccase and
peroxidases is the electron acceptor where oxygen and hydrogen peroxide are the respective electron
acceptors. [38, 39]. Not every WRF species produces all three enzymes, and combination of major LME
varies from one WRF species to another. Even the secretion pattern of enzymes varies within a WRF
species. For instance, different strains of T. versicolor has been reported to secrete all three enzymes but
laccase is the main enzyme secreted by the strain ATCC 7731 [40, 41, 42]. In addition, composition of
4

growth medium and culture conditions can influence the secretion of a specific enzyme. Degradation of
some pollutants such as phenolic compounds, peptides, and organic acids by WRF may result in the
formation of low molecular weight mediators which can enhance the spectrum of compounds degraded by
WRF [37, 39, 43]. Based on the secretion patterns of enzymes, WRF can be categorized as [44]: (i) MnPlaccase group such as T. versicolor, P. ostreatus, D. squalens and P. tigrinus; (ii) LiP-laccase group such
as P. ochraceofulva; and (iii) LiP-MnP group such as P. chrysosporium.
In addition to the extracellular enzymes, intercellular enzymes may play an important role in the
degradation of xenobiotics. Intracellular cytochrome P450 enzyme system has been observed to play a
vital role in the degradation of some PPCPs such as and chlorinated hydrocarbons and polycyclic
aromatic hydrocarbons [45, 46, 47]. Cytochrome P450 is a group of monooxygenases which can degrade
PPCPs by catalyzing a number of reactions such as heteroatom oxygenation, dehalogenation and
hydroxylation [48].

3. Modes of PPCP Degradation by WRF
Different WRF and their LME have been investigated under different experimental conditions for the
removal of PPCPs - either by whole-cell WRF culture or by using the crude and/or purified enzyme
extracts. In this section, different modes of PPCP degradation via WRF and their LMEs are critically
reviewed.

3.1. Removal by Whole-cell WRF
3.1.1.

Degradation capacity of different WRF

Although whole-cell WRF cultures, either in submerged or solid media, have been used for the removal
of PPCPs, submerged whole-cell WRF cultures have been more commonly reported. Since WRF species
harbor different enzyme systems, the extent of PPCP removal achieved by different WRF species also
varies. PPCP removal performance by different WRF species is presented in Table 1. Notably,
temperature and pH for these studies were in the range of 25-30oC and 4.5-5, respectively, with glucose
used as the common electron donor.
5

T. versicolor, also known as Coriolus versicolor [49, 50], has been investigated in several studies for the
removal of PPCPs both in batch and continuous reactors [24, 26, 27, 43, 51, 52, 53]. Depending on the
strain, T. versicolor may contain laccase, LiP and MnP, with laccase being the predominant enzyme in
some strains. It can be observed from Table 1 that T. versicolor achieved significant removal (>70%) for
most of the tested PPCPs. PPCPs such as steroid hormones, nonylphenol and octocrylene can induce
endocrine disrupting effects [54, 55]. Their removal by T. versicolor in literature ranges from 80-99%
regardless of the operating conditions. Conversely, poor and unstable removal was reported for particular
pharmaceuticals namely ciprofloxacine (35%), salicylic acid (0-5%), azithromycin (26%), tetracyclin (05%) and carbamazepine (negligible to 90%). Low and/or unstable removal of these compounds can be
attributed to the presence of strong electron withdrawing functional groups in their chemical structure
[31]. Compared to the pharmaceuticals, the removal of personal care products has been communicated in
only a limited number of studies [27, 52]. However, T. versicolor has been shown to achieve high
removal of ingredients of personal care products such as triclosan, oxybenzone, octocrylene and
nonylphenol (Table 1).
[TABLE 1]
Other WRF species such as P. chrysosporium [56, 57], B. adusta , D. squalens and P. ostreatus
containing different combinations of LMEs have also been investigated for the removal of PPCPs (Table
1). However, these studies reported the removal of only a few PPCPs such as ibuprofen, diclofenac and
triclosan. Despite the difference in enzyme secretion pattern of these WRF, efficient removal (in the range
of 70-99%) was achieved for most tested PPCPs, with uncertain/unstable removal reported for
carbamazepine, which is a known persistent pharmaceutical. It is important to note that a direct
comparison of PPCP removal data from different studies may not be valid due to the differences in
operating conditions and reactor configurations as well as difference in their enzymatic systems.
However, Table 1 serves the purpose of providing a general overview.
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3.1.2.

WRF Reactor configurations

Different reactor configurations have been explored for the continuous treatment of PPCPs in WRF-based
systems (Table 1). Since whole-cell WRF based treatment systems are still in their development phase,
the reactor design and configurations are of significant importance. Hence, the salient features of the
reactor configurations studied to date for the removal of PPCPs, namely, stirred tank bioreactors [56, 57],
bubble column bioreactors, fluidized or packed bed bioreactors [59, 60, 61] and membrane bioreactors
[62, 63, 64, 65] are briefly discussed here to provide a general overview.
Among all the reactor configurations, stirred tank bioreactor has been the most common type of reactor
used for the treatment of PPCPs in WRF based treatment systems. This reactor type has been explored
mostly in batch and sterile modes [56, 57]. In this reactor aeration is provided usually at the bottom of the
reactor which is dispersed via mechanical agitation. Mechanical mixing also ensures the uniform mixing
of the growth medium and wastewater in the reactor [59]. Enhanced production of extracellular enzymes
could be achieved in stirred tank bioreactors compared to other reactor configurations. For instance, Babič
and Pavko [66] investigated the production of laccase and MnP from D. squalens in stirred tank
bioreactor and bubble column reactor under different operating conditions such as incubation time and
agitation speed: they observed that laccase production was as much as 70% higher in the former, although
the production of MnP was comparable [66]. Agitation speed and high shear rate may influence the
morphology of the fungal biomass. In a study by Cao et al. [67], impact of two reactor configurations,
namely stirred tank bioreactor and airlift bioreactor, on the morphology of P. sanguineus was
investigated. They found that the morphology of the fungal biomass was adversely impacted in the stirred
tank bioreactor which uses strong mechanical mixing. Consistent with the finding of Cao et al. [67], it has
been reported that excessive agitation may lead to the rupturing of fungal hyphae [59, 68, 69]. Therefore,
agitation/mixing speed in bioreactors is an important parameter governing fungal morphology and
enzymatic activity.
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Fluidized bed bioreactor is another type that has been used for the removal of PPCPs from municipal and
synthetic wastewater [24, 58]. In this type of reactor, fungal biomass rapidly moves around the solid
carrier (‘bed’), allowing uniform mixing of the reaction mixture [70]. However, aggregation of fungal
biomass may cause poor fluidization, resulting in spouting of bed. Biomass aggregation can be avoided
by intermittent and partial purging of the biomass [71].
A bubble column reactor coupled with a microfiltration membrane has been recently explored for the
removal of PPCPs [26, 27]. Such fungal membrane bioreactor was expected to offer some additional
advantages over bubble column reactors [14, 72, 73] such as: (i) formation of biofilm on the membrane
surface that may enhance the removal of recalcitrant PPCPs; (ii) maintenance of high fungal biomass
concentration improving biodegradation rate; and (iii) effective prevention of enzyme washout.
Nevertheless, bacterial contamination may hamper the growth and enzymatic activity of whole-cell WRF
in any reactor configuration. Impacts of bacterial contamination on WRF are discussed in the next
section.
3.1.3.

Performance under non-sterile environment

The capacity of WRF for PPCP removal has been commonly investigated under sterile conditions to
avoid bacterial contamination. Fungal bioreactors have also been operated under non-sterile conditions
but for a short period of time [24, 26, 58]. Bacterial contamination in the bioreactor adversely affects
PPCP removal efficiency by: (i) creating competition between bacteria and fungi for substrate; (ii)
damaging the fungal mycelium; and (iii) disrupting the growth of fungi [26, 70]. Therefore, it is important
to develop techniques for an uninterrupted growth of fungal strains and to enhance their competitiveness
over bacteria. Some of the strategies to avoid bacterial contamination are outlined below:
(i)

Operation under acidic pH: Optimum pH for the growth and reproduction of fungi ranges from
4.5-5. Conversely, bacteria grow at or near neutral pH. Bacterial growth can be suppressed by
maintaining the pH in the range of 4.5-5. However, this is a temporary solution to the problem of
bacterial contamination because some bacteria can eventually adapt to acidic environment [74].
8

(ii)

Immobilization or attached growth of fungi: Immobilization of fungal strains onto different
carriers under non-sterile conditions shows promising results. For instance, by immobilizing C.
versicolor onto a plastic support, Hai et al. [72] was able to prevent bacterial contamination for an
extended period of time while operating the reactor under non-sterile conditions for the treatment
of an azo dye.

(iii)

Nitrogen limited feed: Bacterial contamination can be avoided by using a media deficient of
nitrogen. However, this strategy can only help during the startup of the bioreactor. Bacterial
contamination would occur with the passage of operating time as bacteria would start consuming
carbon and nitrogen available in fungal mycelium [74].

(iv)

Coupling of bioreactor with micro-screen: Bioreactors can be coupled with a micro-screen which
would retain fungal biomass but allow the washout of bacteria with effluent. Moreover, this
strategy will benefit from using shorter hydraulic retention times, which will enhance the washout
of bacteria from the reactor [75].

(v)

Use of disinfecting agents: Inactivation of bacteria without imposing any harmful effects on
fungal biomass can be a promising strategy. Depending on the wastewater characteristics, it is
important to carefully select the type, dose and contact time of the disinfectant. Disinfection of
wastewater using ozone has been used successfully to selectively inactivate bacteria [76, 77].

(vi)

Biomass replacement: Periodic biomass replacement and purging strategy can be used to carry
out long term operation of fungal bioreactors. In this strategy, biomass in the bioreactor is purged
and renewed in different fractions (e.g., ½ or ¼th of the initial biomass volume) at different
frequencies [78, 79].

(vii)

Pretreatment of wastewater: Coagulation-flocculation pretreatment of non-sterile wastewater can
help to reduce the initial bacterial count which would allow an extended operation of the fungal
bioreactor [79].

9

3.2. Removal by Extracellular LME
Individual extracellular LME have been tested for the removal of a wide range of pollutants. Use of the
harvested enzyme instead of a whole-cell preparation allows decoupling of fungal growth and pollutant
degradation steps and this can be a suitable strategy to avoid bacterial contamination issues. The capacity
of both crude and purified/commercially available extracellular LME for PPCP removal has been reported
previously [27, 41, 42, 80, 81, 82, 83, 84, 85, 86]. However, whole-cell fungi may achieve relatively
better removal of a broader spectrum of pollutants than extracellular LME due to the availability of
extracellular, intercellular and/or mycelium bound enzymes in addition to sorption of pollutants onto
fungal biomass. In this section the performance of crude, purified or commercially available extracellular
enzymes are discussed.
3.2.1.

Performance of Crude LMEs

Crude extracellular enzymes have been investigated for the degradation of PPCPs in both batch and
continuous mode. For instance, Wen et al. [87] achieved significant degradation of two pharmaceuticals,
oxytetracycline (84%) and tetracycline (72%), by using crude MnP (40 U/L) extracted from P.
chrysosporium. Similarly, crude enzyme solution extracted from T. versicolor containing MnP (30 U/L)
and laccase (1500 U/L) was tested for the degradation of 10 pharmaceuticals at an initial concentration of
10 µg/L each [80]. They achieved complete degradation of five pharmaceuticals diclofenac, ibuprofen,
naproxen, indomethacin and fenoprofen, while the rest were partially removed. LiP extracted from P.
chrysosporium was tested for the degradation of diclofenac and carbamazepine at different pH [88]. It
was observed that degradation of carbamazepine was mostly <10%, whereas a complete degradation was
achieved for diclofenac at pH 3-4.5. Similarly, crude extract from T. versicolor was used for the removal
of 30 TrOCs including PPCPs [81]. The results revealed that all steroid hormones were almost completely
removed (>95%), while removal of two PPCPs namely diclofenac and triclosan ranged from 50-60% with
poor removal of the remaining PPCPs (<20%). In another study [89], crude enzyme extract from P.
ostreatus achieved low removal (<20 %) for two PPCPs, namely, oxybenzone and naproxen. Since WRF
10

also secretes natural mediators along with LMEs, crude enzyme may achieve better PPCP removal
efficiency compared to purified and/or commercially available LME. For instance, Tran et al. [80]
highlighted that complete removal (>99%) of some pharmaceuticals such as diclofenac, indomethacin and
ibuprofen was due to the presence of some natural mediators in crude laccase solution.
Removal performance of selected PPCPs by individual crude enzymes has been systematically presented
in Table 2. It can be seen that the extent of PPCP removal is different for each type of LME. Moreover,
crude enzyme extract from different fungi may perform differently. For instance, Weng et al. [90]
collected crude LiP from two WRF species, namely, P. sordida and P. chrysosporium for the treatment of
EDCs and found that LiP from P. sordida was more effective than LiP from P. chrysosporium. Similarly,
removal of DEET, an insect repellent, by T. versicolor was 55% in real wastewater compared to its 20%
removal in acetate buffer. High removal of DEET in real wastewater was attributed to the presence of
other compounds (such as phenolic compounds) which may act as redox-mediators [91], as further
discussed in a following section.
[TABLE 2]
3.2.2.

Performance of Purified LME

Purified LME, mostly laccase from different WRF, has been used for the treatment of PPCPs in both
batch and continuous reactors. Average removal of PPCPs by purified laccase reported in recent studies is
presented in Figure 1. Purified laccases are more effective for the removal of phenolic compounds such as
oxybenzone, triclosan and steroid hormones. Removal of non-phenolic compounds such as
carbamazepine, naproxen and ketoprofen is generally poor/unstable. Their degradation depends on their
physicochemical properties such as hydrophobicity and chemical structure as well as the oxidation
reduction potential (ORP) of the enzyme [31, 102]. Indeed, based on the results of the recent studies
incorporated in Figure 1, removal of phenolic compounds ranges from 70-99%, while the removal of nonphenolics is generally <20%. However, relatively higher removal of some non-phenolic compounds,
namely, diclofenac (40-50%), octocrylene (>80%) and ibuprofen (30-45%) has been reported because
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these compounds contain both electron donating and electron withdrawing functional groups. Although
both crude and purified LMEs demonstrated degradation of a range of pollutants, crude LMEs achieved
better removal of some PPCPs such as diclofenac and naproxen compared to purified LMEs [27, 41, 81,
82, 83, 85], possibly due to the presence of natural mediators in crude LMEs secreted by WRF. For
instance, Tran et al. [80] achieved almost complete removal of three pharmaceuticals namely diclofenac,
ibuprofen and naproxen after treatment with crude enzyme extracted from T. versicolor, whereas purified
laccase from T. versicolor and A. oryzae achieved 20-50% removal of these compounds [82, 83, 84, 103].
Additionally, utilization of crude LMEs for the treatment of PPCPs may considerably reduce the cost of
the treatment process. However, extracellular extract i.e., the crude enzyme solution also contains
significant amount of the unspent growth media, and dosing crude enzyme means additional organic
loading from this.
[FIGURE 1]

3.3. Performance of Redox-mediator Enhanced Laccase Catalyzed System
Laccase catalyzes mono-electronic oxidation of PPCPs. However, the extent of removal depends on the
ORP of the enzyme and individual PPCP. Poor removal of non-phenolic PPCPs can be attributed to: (i)
presence of a strong EWG in the structure of non-phenolic compounds causing steric hindrance; and (ii)
higher ORP of non-phenolic compounds than laccase [102]. Removal of non-phenolic compounds can be
enhanced by introducing a low-molecular weight redox-mediator. In a redox-mediator catalyzed system,
highly reactive radicals are formed due to the oxidation of a mediator by laccase and these radicals then
serve as an electron transfer shuttle between PPCPs and laccase, facilitating enhanced removal of
recalcitrant compounds. Three oxidation mechanisms, namely hydrogen atom transfer (HAT), ionic
mechanisms and electron transfer have been reported for mediators. For instance, 1-hydroxybenzotriazole
(HBT) and syringaldehyde (SA) follow HAT mechanism, while 2,2-azino-bis(3-ethylbenzothiazoline-6sulfnoic acid (ABTS) and 2,2,6,6-tetramethylpiperidinyloxyl (TEMPO) follow electron transfer and ionic
mechanisms, respectively [89, 109].
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Properties of different redox-mediators used to enhance the removal of different PPCPs are summarized
in Table 3. Although the mediators perform differently, two mediators namely HBT and SA have been
commonly used to broaden the spectrum of compounds significantly degraded by laccase. Studies
involving these mediators confirmed that they not only improved the ORP of reaction mixture but also the
extent of removal. Only a few studies elucidated the performance of different mediators based on the type
of substrate (i.e., phenolic vs. non-phenolic). For instance, N-OH type mediators (VA and HBT) were
found to achieve the best removal of non-phenolic PPCPs such as clofibric acid, naproxen and
carbamazepine, whereas SA and ABTS performed better for phenolic compounds such as salicylic acid
and steroid hormones [82, 83, 85].
Mediator type, concentration and compound properties influence the performance of a mediator catalyzed
system. For instance, removal of diclofenac improved from 40 to 80% by increasing the concentration of
SA from 0.1 to 0.5 mM [103]. Similarly, Nguyen et al. [85] achieved an improvement of 35% in the
removal of diclofenac in an enzymatic membrane reactor by increasing the dose of SA from 0.01 mM to
0.1 mM. However, beyond a threshold concentration increasing mediator dose may not improve the
removal of PPCPs. For instance, Ashe et al. [89] observed that increasing the concentration of VA and
ABTS from 0.5 to 1 mM could not enhance the removal of oxybenzone and naproxen. They also
observed that removal of atrazine was reduced by 15-25 % when the concentration of VA and HBT was
increased from 0.1 to 0.25 mM. This may be attributed to the complex interactions between laccase and
the radicals generated due to degradation of the mediator by laccase, as discussed below.
[TABLE 3]
It has been observed in almost all the studies that enzymatic activity significantly drops with the addition
of mediators. For instance, Hata et al. [111] observed 90% decline in enzymatic activity within fist 8 h of
incubation in the presence of HBT. Similarly, rapid decline in enzymatic activity was also observed with
the addition of VA, HBT or ABTS [89], although rate of enzyme inactivation depends on the relative
stability of the radicals generated by mediators. In the absence of any known enzyme inhibitor, rapid
13

enzyme inactivation in mediator catalyzed system can be attributed to: (i) the blockage of active sites of
the enzyme by charged radicals and metabolites; and (ii) the reaction of metabolites with enzyme-active
sites to convert them into non-productive complexes [112, 113].
Despite rapid inactivation of enzymes by different mediators, mediators can compensate by enhancing the
rate of reaction, eventually achieving rapid and enhanced removal of PPCPs. However, periodic
replenishment of enzyme is needed to maintain the removal efficiency of PPCPs, constraining the long
term operation of mediator-enzyme based wastewater treatment processes. Therefore, selection of
mediator type and its concentration is vital for effective and long term operation of such systems.

4.

Impacts of Physicochemical Characteristics of Wastewater

Performance of WRF in wastewater treatment depends on a number of factors such as environmental
conditions and physiochemical properties of the wastewater as well as the properties of PPCPs. Influence
of PPCP properties on their overall removal in a WRF mediated treatment process has been reviewed by
Yang et al. [31]. Briefly, physicochemical properties of water/wastewater such as pH, temperature and the
presence of dissolved organic and/or inorganic compounds may influence WRF performance. Because
information about these properties are vital to design and optimize WRF mediated treatment systems,
these are discussed in this section.
The operating temperature not only affects the stability of WRF enzymatic systems but also the rate of
reaction. It is believed that the rate of reaction increases with increase in temperature [88]. However,
depending on the WRF strain, rapid thermal inactivation of LMEs has been observed at temperature
>40oC [114, 115]. Only a few studies have investigated the impact of temperature on LME activity and
removal efficiency in a reaction mixture. For instance, increase in temperature of the reaction mixture
from 20 to 25oC enhanced the removal efficiency of chlorophenols in laccase mediated treatment [116].
Similarly, Ullah et al. [117] investigated the removal of pentachlorophenol by varying the temperature
from 10-45 oC and found that the optimal temperature was 25oC to achieve maximum laccase activity and
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pentachlorophenol removal. Temperature range of 37-40 oC has been reported to achieve optimal activity
of MnP and LiP [87, 118].
Enzyme performance and substrate properties can be influenced by pH of the reaction mixture, thereby
affecting the extent of PPCP removal. For instance, optimum pH for the removal of diclofenac (60-100%)
by purified laccase (T. versicolor and M. thermophile) and LiP (P. chrysosporium) was in the range of 3.0
– 4.5 [83, 88, 103, 105]. Similarly, Wen et al. [87] observed that the removal of two antibiotics, namely
tetracycline and oxytetracycline, by crude LiP and MnP was pH dependent and the best removal was
achieved at pH 4.5-5.0. However, optimum pH for the removal of a personal care product triclosan was in
the range of 5-5.5 during the treatment with laccase from T. versicolor [93, 116]. Media pH may not
affect the removal of compounds highly amenable to laccase-catalyzed degradation. For instance, laccase
from T. versicolor achieved significant removal (>70%) of steroid hormones over a pH range of 4 - 7
[103]. Similarly, changing the pH from 2.5- 6 could not improve the removal of carbamazepine by LiP
[88]. In light of the above discussion, pH ranging from 4-5-5 is recommended for WRF mediated
treatment processes.
The impact of dissolved organic and inorganic constituents on laccase activity and PPCP removal has
been communicated in a limited number of studies. Many compounds such as sulphides, halides [119,
120], natural/synthetic organics [121, 122, 123, 124, 125, 126] and heavy metals [92, 127] can inhibit the
catalytic activity of laccases [128]. Moreover, each compound may have different mode of laccase
inhibition. For instance, fatty acids inhibit laccase catalytic potential by blocking the binding sites for
phenolic substrates [129, 130, 131]. On the other hand, spectrophotometric assays, electron spin
resonance spectroscopy and catalytic voltammetry analysis confirmed that anionic inhibitors such as
halides and sulphides could block the access to the active copper sites in laccase [132, 133, 134]. Among
anionic inhibitors, fluoride and azide are the most effective and can rapidly reduce the catalytic activity of
laccase by 50% even at µM concentrations [135]. Although inhibition of laccases by halides can proceed
in the following order: fluoride > chloride > bromide, the concentration of halides required to inhibit
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laccases varies, with no fixed correlation with their inhibition potential. For instance, chloride
concentration ranging from 100 µM – 100 mM may cause a 50% drop in activity of laccase from different
species [35, 136].

5.

Removal Mechanisms

Removal mechanisms during treatment with WRF whole-culture include (i) sorption onto the fungal
biomass; (ii) degradation by extracellular enzymes; and (iii) degradation by mycelium bound or
intercellular enzymes. A schematic of fungal mediated treatment process with possible removal
mechanisms is presented as Figure 2. Hydrophobicity (log D) of PPCPs is a key property that governs
biosorption onto fungal biomass and could facilitate enhanced removal of some compounds. For instance,
a batch study to investigate the contribution of biosorption and degradation by extracellular enzymes
confirmed that hydrophobic PPCPs (log D>4) were highly removed by both mechanisms [41]. Moreover
this study also confirmed that biosorption of significantly hydrophobic compounds facilitated the
biodegradation of these compounds. On the other hand, a few studies have reported that removal of some
PPCPs such as 17β-Estradiol, 17α-Ethynylestradiol, triclosan and nonylphenol by whole-cell WRF and
extracellular enzymes is comparable (see Table 1 and 2), indicating a negligible impact of biosorption on
their removal.
Biodegradation by whole-cell can be due to intracellular, extracellular and mycelium-associated enzymes.
This can lead to significant differences in removal by whole-cell WRF and harvested enzyme. For
instance, carbamazepine, containing a strong EWG, was significantly removed by some WRF species
namely P. ostreatus (100%) [45] and T. versicolor ATCC 42530 (76%) [80], whereas crude [45, 80, 81]
and purified laccase [82, 85] could only achieve 5-15% carbamazepine removal. Similarly, ibuprofen and
naproxen were almost completely removed by whole-cell WRF [24, 43, 58]. In contrast, their removal by
crude and purified laccase was in the range of 10-40% [27, 82, 85, 103]. Since both naproxen and
ibuprofen are hydrophilic compounds (log D <3), role of biosorption in their removal would be limited.
However, almost complete removal of these compounds in whole-cell WRF substantiates the role of
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mycelium bound and/or or intercellular enzymes. Indeed, the role of intercellular enzyme (i.e. cytochrome
P450) in the degradation of naproxen, diclofenac and carbamazepine has been demonstrated [43, 45, 137].
These studies showed that naproxen, diclofenac and carbamazepine were partially removal (15-50%) in
the presence of cytochrome P450 inhibitor during whole-cell WRF treatment. Therefore, it can be
concluded that high removal of some PPCPs in whole-cell WRF treatment is due to the synergetic effects
of extracellular, intercellular and/or mycelium bound enzymes. Moreover, secretion of natural mediators
may also help in enhancing the removal of these compounds.
[FIGURE 2]

6.

Degradation Pathways and Identification of Intermediates

PPCP degradation pathways and their intermediate products have been identified for some compounds
such as carbamazepine, diclofenac, triclosan and ibuprofen. However, each WRF species may follow a
different degradation pathway. Degradation pathways and intermediate products of some PPCPs are
discussed in this section.
Fungal mediated treatment of diclofenac starts with the conversion of the hydroxyl group in its structure
into an intermediate product, namely, hydroxy diclofenac. Hydroxy diclofenac can be amenable to further
fungal biodegradation [137, 138]. In vivo and in vitro experiments for the degradation of diclofenac
showed that laccase (T. versicolor) catalyzed degradation leads to the formation of biodegradable
compounds such as: (i) hydroxelated metabolites (appeared in both in vivo and in vitro experiments); and
(ii) 4-(2,6 dichlorophenylamino)-1,3-benzenedimethanol metabolite (appeared only in in vivo
experiments) [138]. Diclofenac and its metabolites both disappeared after 24 h of incubation, reducing the
ecotoxicity of the treated effluent. Degradation of ketoprofen was reported to initiate by the intercellular
cytochrome P450 that converts ketoprofen into (2-[3-(4-hydroxybenzoyl)phenyl]-propanoic acid) and (2[(3-hydroxy(phenyl)-methyl)phenyl]-propanoic acid) via hydroxylation and reduction of the ketone
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group, respectively [138]. Moreover, it was also observed that the role of extracellular enzyme (laccase)
in the degradation of ketoprofen was insignificant.
Both laccase and cytochrome P450 can catalyze the degradation of naproxen in WRF based treatment.
Formation of two intermediates, namely 6-desmethylnaproxen and 1-(6-methoxynaphthalen-2yl)ethanone), was observed possibly via P450-mediated desmethylation and laccase catalysis, respectively
[43, 57]. Moreover, naproxen and associated intermediates were completely removed from the reaction
mixture and the treated effluent was non-toxic [43].
Ibuprofen conversion predominantly starts with the formation of hydroxy-ibuprofen via hydroxylation.
Marco-Urrea et al. [139] investigated the degradation pathways of ibuprofen by WRF T. versicolor. They
observed that oxidation of isopropyl chain resulted in the formation of 1-hydroxy ibuprofen and 2hydroxy ibuprofen. These intermediates were then degraded by T. versicolor to 1,2-dihydroxy ibuprofen,
which was not further degraded. Hence, the ecotoxicity of treated effluent was higher than that of the
initial solution [139].
Degradation pathways for carbamazepine by different whole-cell WRF including T. versicolor and P.
ostreatus have also been studied. These have identified a number of stable intermediate products namely,
10,11-dihydro-10,11-dihydroxy-carbamazepine, acridine, acridone and 10,11-epoxy-carbamazepine.
Interestingly, the treated effluent showed less toxicity [45, 53].
Intermediates or metabolites of triclosan during whole-cell treatment depends on WRF species. Major
intermediates of triclosan during the treatment with C. polyzona WRF were dimer, trimer and tetramer
[140], while 2-O-(2,4,4-trichlorodiphenyl ether)-b-D-xylopyranoside, 2-O-(2,4,4-trichlorodiphenyl ether)b-D-glucopyranoside and 2,4-dichlorophenol were identified as major intermediates following its
treatment with T. versicolor [141].

18

7.

Future Scope of Research

Performance of whole-cell WRF has mostly been investigated in sterile batch tests. Only a few studies
have been conducted in continuous flow reactors under non-sterile conditions [24, 26, 27, 58], because
bacterial contamination can seriously affect WRF performance. Therefore, more efforts are required to
solve this limitation.
Another limitation of WRF mediated treatment process is the washout of the enzyme and mediators with
treated effluent. This is particularly problematic for enzymatic reactors where enzymes instead of wholecell WRFs are used. Enzyme immobilization or coupling of enzymatic reactor with a membrane with
suitable pore size can be used to avoid enzyme washout [27, 82, 83, 85, 142, 143]. Coupling of membrane
separation with an enzymatic reactor offers several advantages over immobilized enzymatic systems such
as: (i) more effective enzyme retention; (ii) reduced mass transfer limitations; (iii) ease of enzyme
replenishment and (iv) ease of operation and maintenance [29, 144]. Moreover, enhanced TrOC removal
by enzymatic membrane bioreactors (EMBR) has been demonstrated in a few recent studies [82, 83].
While investigating the removal of 30 TrOCs in an EMBR, Nguyen et al. [82] observed retention of
PPCPs such as gemfibrozil, naproxen and ketoprofen on the enzyme gel layer formed over the membrane.
It was also confirmed that the compounds retained by the enzyme gel layer were subsequently
biodegraded [82]. Despite enhanced removal of some PPCPs, EMBR may not be effective to protect
enzymes from thermal and chemical denaturation. In such situations, immobilized enzymatic systems
have been reported to be more effective than free enzymes [145, 146, 147]. In enzyme-mediator systems,
redox-mediators may still pass through the membrane with the treated effluent, thus increasing the
operating costs. Washout of redox-mediators can be prevented by integrating a high retention membrane
such as nanofiltration, membrane distillation or forward osmosis membrane with the enzymatic reactor, or
formulating strategies to recover mediators from effluent.
Degradation pathways of only a few PPCPs such as carbamazepine, diclofenac, ibuprofen and naproxen
have been reported in literature. The intermediate products in some cases are more toxic than the parent
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compound. Therefore, more efforts are required to identify and elucidate the formation of intermediate
products during WRF mediated treatment of PPCPs which would help to further understand the
degradation mechanisms of PPCPs.

8.

Conclusion

WRF mediated treatment of PPCPs is a promising and environmentally friendly technology. Varieties of
PPCPs are efficiently removed by both whole-cell WRF and crude/purified LMEs. Hydrophilic and
persistent PPCPs such as naproxen, ketoprofen and carbamazepine are significantly removed only in
whole-cell WRF treatment because of the synergistic effects of extracellular and intercellular enzymes as
well as sorption onto fungal biomass. Different redox-mediators have been introduced to enhance the
removal of persistent PPCPs but continuous addition of mediators is an expensive practice. Therefore,
mediator type and concentration must be selected carefully and techniques to recover mediators be
optimized. Operating conditions of the enzymatic reactor including pH, temperature and interfering
dissolved contaminants could influence the performance of WRF mediated treatment process. Despite the
better performance of whole-cell WRF treatment than crude and purified enzymes, long term continuous
operation of fungal bioreactor could not be possible due to bacterial contamination. This problems needs
to be solved before their full scale applications.
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List of Tables
Table 1: Removal (%) of PPCPs by different species of WRF (whole-cell) under different operating conditions
WRF Specie

Reactor Type
Stirred tank
(Batch-fed)

P. chrysosporium
(LiP, MnP)

Stirred tank
(Continuous)

Fixed bed
(Continuous)

Operating conditions
Inoculum= 1.2 g/L
Reactor volume = 2 L, HRT= 24 h
Mixing speed = 200 rpm
pH = 4.5; Temperature= 30oC
Electron donor= glucose
Operating time= 30 days
Reactor volume = 1.5 L
HRT= 24 h
pH = 4.5; Temperature= 30oC
Electron donor= glucose
Operating time= 50 days
Inoculum= 3.2 g/L
Reactor volume = 0.13 L
HRT= 120 days

PPCPs
Diclofenac
Ibuprofen
Naproxen

Diclofenac
Ibuprofen
Naproxen
Carbamazepine
Diazepam

Initial
concentration
(mg/L)
0.8
0.8
0.8

Removal
efficiency (%)
>99
75-99
>99

1
1
1
0.5
0.25-0.5

92
95
95
25-60
0

17β-estradiol (E1)
17αethynylestradio
(EE2)

3-18.8

>95

7.3

>95

Carbamazepine

0.05-9

61-94

References

[56]

[57]

[51]

o

T. versicolor
(Laccase, LiP, MnP)

Fluidized bed
(Batch-fed)

Fluidized bed
(Batch-fed)

Fluidized bed

pH = 4.5; Temperature= 22 C
Electron donor= glucose
Operating time= 26 days
Inoculum= 3.8 g
Reactor volume = 1.5 L
pH = 4.5; Temperature= 25oC
Electron donor= glucose
Operating time= 15 days
Inoculum= 1.5 g/L
Reactor volume = 10 L
pH = 4.5; Temperature= 25oC
Electron donor= glucose
Operating time= 8 days
Real hospital wastewater
Non sterile conditions
Inoculum= 1.4 g/L

[53]

Ibuprofen
Acetaminophen
Ketoprofen
Ciprofloxacine
Azithromycin
Propranolol
Carbamazepine
Acetaminophen
30

2.34
1.56
0.08
84.71
4.31
0.06
0
109

100
100
100
35
100
100
-50
100

[24]

[58]

(Continuous)

Reactor volume = 10 L
pH = 4.5; Temperature= 25oC
Electron donor= glucose
Operating time= 8 days
Real hospital wastewater
Non sterile conditions

Membrane
bioreactor
(Continuous)

Inoculum= 3.5 g/L

Membrane
bioreactor
(Continuous)

Reactor volume = 5.5 L, HRT= 1
day
pH = 5.4; Temperature= 27oC
Operating time= 90 days
Non sterile conditions
Inoculum= 3 g/L
Reactor volume = 5.5 L, HRT= 2
day
pH = 4.5; Temperature= 27oC
Operating time= 110 days
Non sterile conditions

Naproxen
Ibuprofen
Ketoprofen
Diclofenac
Codeine
Phenazone
Salicylic Acid
Ofloxacin
Ciprofloxacine
Sulfamethoxazole
Trimethoprim
Metronidazole
Azithromycin
Clarithromycin
Erithromycin
Tetracyclin
Caffeine
Carbamazepine
Atenolol
Metoprolol
Diclofenac

1.62
35.5
2.17
0.477
0.606
0.497
0.606
3.34
13.0
1.41
0.853
0.912
1.37
2.20
0.008
0.011
149
0.056
2.99
0.019

100
100
95
100
100
96
0
98
99
100
100
85
26
80
100
0
39
0
75
95

0.3-1.5

55
[26]

Ibuprofen
Naproxen
Ketoprofen
Diclofenac
Carbamazepine
Metronidazole
Gemfibrozil
Amitriptyline
Estriol (E3)
17-β-estradiol
31

0.005

95

0.005

95

0.005
0.005
0.005
0.005
0.005
0.005
0.005
0.005

90
50
20
40
95
85
>95
>95

[27]

Erlenmeyer
flask
(Batch-fed)

P. ostreatus
(Laccase, MnP)

D. squalens
(Laccase, MnP)

B. adusta
(Laccase, LiP, MnP)

Erlenmeyer
flask
(Batch-fed)

Erlenmeyer
flask
(Batch-fed)

Erlenmeyer
flask
(Batch-fed)

17-β-estradiol –
acetate
17-α
ethinylestradiol
Triclosan
Benzophenone
Oxybenzone
Octocrylene
Triclosan

Inoculum= 2-3 mg/test
o

pH = 4.5; Temperature= 28 C
Operating time= 14 days
Electron donor: glucose
Inoculum= 2-3 mg
pH = 4.5; Temperature= 28oC
Operating time= 14 days
Electron donor: glucose
Inoculum= 2-3 mg
pH = 4.5; Temperature= 28oC
Operating time= 14 days
Inoculum= 2-3 mg
pH = 4.5; Temperature= 28oC
Operating time= 14 days

17-α
ethinylestradiol
Nonylphenol
Triclosan
17-α
ethinylestradiol
Nonylphenol
Triclosan
17-α
ethinylestradiol
Nonylphenol
Triclosan
17-α
ethinylestradiol
Nonylphenol

32

0.005

>95

0.005

>95

0.005
0.005
0.005
0.005

95
80
92
94

10

98

10

94

10

90

10

98

10

62

10

93

10

98

10

78

10

85

10

98

10

78

10

85

[52]

[52]

[52]

[52]

Table 2: Performance of crude LME for the removal (%) of PPCPs
PPCPs
Non-phenolic compounds
Carbamazepine
Ibuprofen
Naproxen
Diclofenac
Gemfibrozil
ketoprofen
Clofebric acid
Benzophenone
DEET
Octocrylene
Phenolic compounds
Estrone
17β-Estradiol
17α-Ethynylestradiol
Oxybenzone
Nonylphenol
Triclosan
“-”: not reported

Laccase [80, 81, 89, 91, 92, 93, 94, 95, 96, 97, 98, 99]
Initial
Removal
Incubation
concentration
(%)
time (h)
(mg/L)
5 – 37
0.01-0.1
24-48
<5 – 38
0.01-0.1
24-48
20-100
0.01-0.5
24-48
60-100
0.01-0.1
3-48
20-25
0.01-0.1
24-48
<5 -12
0.01-0.1
24-48
10-20
0.01-0.1
24-48
<5
0.1
24
20-55
0.01
4
20
0.1
24
70-100
>99
>99
10-25
100
70-90

0.1-27
0.01-5
0.1-2.96
0.1-0.5
22
0.1-144

1-24
1-24
1-24
24
1
24

<10
>99
-

LiP [88, 90, 100]
Initial
concentration
(mg/L)
5
5
-

60
40, 85
20, 82
-

27
0.6, 27
6.6, 30
-

Removal
(%)

33

Incubation
time (h)
2
2
24
1, 24
8, 24
-

MnP [80, 95, 96, 101]
Initial
Removal
Incubation
concentration
(%)
time (h)
(mg/L)
14-20
0.01-4.7
24-48
20
0.01
48
95
0.01
48
100
0.01
48
30
0.01
48
22
0.01
48
<10
0.01
48
>99
>99
>99
-

5
2.96
2.96
-

8
1
1
-

Table 3: Properties of redox-mediators used to improve the performance of laccase based treatment of PPCPs

Redox-mediator

Type of mediator

Free radicals

1-hydroxibenzotriazole (HBT)

N-OH/ synthetic

aminoxyl

Violuric acid (VA)

N-OH/ natural

aminoxyl

N-hydroxyphthalimide (HPI)

N-OH/ synthetic

aminoxyl

Syringaldehyde (SA)
Vanillin (VAN)
2,2,6,6-tetramethylpiperidinyloxyl (TEMPO)
2,2-azino-nis(3-ethylbenzothiazoline-6sulfnoic acid (ABTS)

C6H4(OH)(OCH3)/
natural
C6H4(OH)(OCH3)/
synthetic
N – O / synthetic

phenoxyl
phenoxyl
Oxoammonium

Oxidation
mechanism
Hydrogen atom
transfer
Hydrogen atom
transfer
Hydrogen atom
transfer
Hydrogen atom
transfer
Hydrogen atom
transfer
Ionic

+

ABTS/ synthetic

ABTS and
ABTS++

34

Electron transfer

Application for TrOC
removal
PPCPs, EDCs, pesticides
and industrial chemicals
PPCPs, pesticides and
industrial chemicals

References
[43, 81, 89, 104,
105, 110]
[89, 90]

PPCPs and pesticides

[89]

PPCPs, EDCs, pesticides
and industrial chemicals
PPCPs, EDCs, pesticides
and industrial chemicals
PPCPs, EDCs, pesticides
and industrial chemicals
PPCPs, EDCs, pesticides
and industrial chemicals

[82, 83, 84, 85,
89]
[89, 90, 110]
[89, 90, 110]
[89, 90]

Phenolic PPCPs

35
Amitriptyline (3)

Benzophenone (3)

Octocrylene (2)

Sulfamethoxazole (2)

Carbamazapine (3)

Clofibric acid (2)

Ibuprofen (2)

Fenoprop (3)

Diclofenac (7)

Metronidazole (3)

Gemifibrozil (3)

Naproxen (3)

Ketoprofen (2)

Primidone (2)

Formononetin (2)
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Figure 1. Average removal of phenolic and non-phenolic PPCPs after treatment with
purified/commercially available laccase. Error bar indicates average±standard deviation. Numbers within
parenthesis indicates number of data points. Data was collected from the following studies: [82, 83, 84,
85, 103, 104, 105, 106, 107, 108].

Figure 2. A schematic representation of whole-cell WRF mediated treatment process
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